Progress in multiple myeloma

Affiliations

Comment

Reinhold Munker et al. Indian J Med Res. 2019 Jun.

. 2019 Jun;149(6):693-694.

doi: 10.4103/ijmr.IJMR_770_19.

¹ Department of Internal Medicine, Division of Hematology & BMT, University of Kentucky, Lexington, KY 40536, USA.

No abstract available

Conflict of interest statement

None

High-dose chemotherapy followed by autologous stem cell transplant for multiple myeloma: Predictors of long-term outcome.
Kumar L, Ramavath D, Kataria B, Tiwari A, Raj A, Chellapuram SK, Mookerjee A, Sahoo RK, Malik PS, Sharma A, Gupta R, Sharma OD, Biswas A, Kumar R, Thulkar S; for AIIMS Myeloma Group. Kumar L, et al. Indian J Med Res. 2019 Jun;149(6):730-739. doi: 10.4103/ijmr.IJMR_1593_18. Indian J Med Res. 2019. PMID: 31496525 Free PMC article.

1. Palumbo A, Anderson K. Multiple myeloma. N Engl J Med. 2011;364:1046–60. - PubMed
1. Kyle RA. Multiple myeloma: An odyssey of discovery. Br J Haematol. 2000;111:1035–44. - PubMed
1. Hussein M. Multiple myeloma: An overview of diagnosis and management. Cleve Clin J Med. 1994;61:285–98. - PubMed
1. Al Hamed R, Bazarbachi AH, Malard F, Harousseau JL, Mohty M. Current status of autologous stem cell transplantation for multiple myeloma. Blood Cancer J. 2019;9:44. - PMC - PubMed
1. Kumar SK, Rajkumar V, Kyle RA, van Duin M, Sonneveld P, Mateos MV, et al. Multiple myeloma. Nat Rev Dis Primers. 2017;3:17046. - PubMed